Advertisement

Naunyn-Schmiedebergs Archiv für Pharmakologie

, Volume 268, Issue 4, pp 379–391 | Cite as

Beeinflussung der calorigenen Wirkung von sympathomimetischen Aminen durch Lithium

  • K. Opitz
  • H. Chu
  • H. Grüter
Article

Influence of lithium on the calorigenic action of sympathomimetic amines

Summary

The influence of lithium on the oxygen uptake and the calorigenic actions of norepinephrine (NE), isoprenaline, amphetamine, and 2,4-dinitrophenol (DNP) was studied in rats. The metabolic rate of animals which had received LiCl with the drinking water to give plasma lithium levels of 0.09–1.14 mEq/l was low and the calorigenic effect of NE was reduced. When LiCl was injected in large doses (giving plasma lithium levels up to 4.65 mEq/l) the metabolic rate was not altered but the calorigenic effect of NE, and to a lesser degree also that of isoprenaline and amphetamine, was reduced while the DNP-induced calorigenesis was enhanced. Lithium impaired the ability of rats to compensate for heat losses in a cold environment.

Some of the lithium-watered rats showed morphological signs of hypothyroidism but iodine uptake by the thyroid gland was only reduced when LiCl was injected. Results obtained with the Thyopac-3 test did not show any decrease in secretion of thyroid hormone.

Since the calorigenic response to DNP is not impaired by pretreatment with LiCl, hypothyroidism, if present at all, does not appear to be the cause of the reduced activity of NE and other Sympathomimetic amines in lithium-treated animals. It is more probable that lithium acts by altering uptake and release of monoamines.

Key-words

Lithium Oxygen Consumption Catecholamines Amphet-amine Dinitrophenol Thyroid Gland 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Barke, R., Gursky, S.: Der Radiojodtest bei der Ratte. Rad. biol. ther.5, 511–516 (1964).Google Scholar
  2. Berens, S. C., Bernstein, R. S., Robbins, J., Wolff, J.: Antithyroid effects of lithium. J. clin. Invest.49, 1357–1367 (1970).Google Scholar
  3. Bickel, M. H.: Untersuchungen zur Biochemie und Pharmakologie der Thymoleptika. In: Fortschritte der Arzneimittelforschung, Bd.11, S. 121–225. Hrsg. von E. Jucker. Basel-Stuttgart: Bifkhäuser 1968.Google Scholar
  4. Cade, J. F. J.: Lithium salts in the treatment of psychotic excitement. Med. J. Aust.36, 349–352 (1949).Google Scholar
  5. Carlson, L. D.: The role of catecholamines in cold adaptation. Pharmacol. Rev.18, 291–301 (1966).Google Scholar
  6. Chu, H., Opitz, K.: Zur Wirkung von Isopropoxamin und Butoxamin auf den respiratorischen Stoffwechsel. Arch. int. Pharmacodyn.183, 224–234 (1970).Google Scholar
  7. — —: Intemann, E.: Über die Bedeutung der Schilddrüse für die stoffwechselsteigernde Wirkung von Amphetamin. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path.263, 358–362 (1969).Google Scholar
  8. Clark, F.,Brown, H. J.: Evaluation of Thyopac-3 test in the in-vitro assessment of thyroid function. Brit. med. J.1970 I, 713–715.Google Scholar
  9. Colburn, R. W., Goodwin, F. K., Bunney, W. E., Jr., Davis, J. M.: Effect of lithium on the uptake of noradrenaline by synaptosomes. Nature (Lond.)215, 1395–1397 (1967).Google Scholar
  10. Diding, N., Ottosson, J.-O., Schou, M. (Editors): Lithium in psychiatry. Acta psychiat. scand., suppl.207, 1–105 (1969).Google Scholar
  11. Fieve, R. R., Platman, S.: Lithium and thyroid function in manic-depressive psychosis. Amer. J. Psychiat.125, 527–530 (1968).Google Scholar
  12. Gonzales, R., Lauter, H.: Zur Therapie manisch-depressiver Psychosen mit Lithiumsalzen. Nervenarzt33, 11–16 (1968).Google Scholar
  13. Holtz, P., Palm, D.: Brenzkatechinamine und andere sympathomimetische Amine. Biosynthese und Inaktivierung, Freisetzung und Wirkung. Ergebn. Physiol.58, 1–580 (1966).Google Scholar
  14. Katz, R. I., Chase, T. N., Kopin, I. J.: Evoked release of norepinephrine and serotonin from brain slices: Inhibition by lithium. Science162, 466–467 (1968).Google Scholar
  15. Kopin, I. J.: How does lithium work? New Engl. J. Med.280, 560–561 (1969).Google Scholar
  16. Lauter, H.: Zum gegenwärtigen Stand der Lithium-Therapie. Dtsch. med. Wschr.94, 2512–2518 (1969).Google Scholar
  17. Leduc, J.: Cateoholamine production and release in exposure and acclimation to cold. Acta physiol. scand.53, suppl. 183, 5–101 (1961).Google Scholar
  18. Nash, C. W., Wolff, S. A., Ferguson, B. A.: Release of tritiated noradrenaline from perfused rat hearts by sympathomimetic amines. Canad. J. Physiol. Pharmacol,46, 35–42 (1968).Google Scholar
  19. Opitz, K., Chu, H.: Zur stoffwechselsteigernden Wirkung der Brenzcatechinamine. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path.259, 329–343 (1968).Google Scholar
  20. Schanberg, S. M., Schildkraut, J. J., Kopin, I. J.: The effects of psyehoactive drugs on norepinephrine-3H metabolism in brain. Biochem. Pharmacol.16, 393–399 (1967).Google Scholar
  21. Schildkraut, J. J., Schanberg, S. M., Breese, G. E., Kopin, I. J.: Norepinephrine metabolism and drugs used in the affective disorders: A possible mechanism of action. Amer. J. Psychiat.124, 600–608 (1967).Google Scholar
  22. Schou, M.: Lithium: Ein Spezificum gegen manisch-depressive Psychose. Arzneimittel-Forsch.17, 172–176 (1967).Google Scholar
  23. —: Lithium als Psychopharmakon. Fortschr. Neurol. Psychiat.37, 349–383 (1969 a).Google Scholar
  24. —: Mℷliche Wirkungsmechanismen des Lithiums. In: Das depressive Syndrom, S. 9–15. Hrsg. von H. Hippius u. H. Selbach. München-Berlin-Wien: Urban. & Schwarzenberg 1969b.Google Scholar
  25. —, Amdisen, A., Jensen, S. E., Olsen, T.: Occurrence of goitre during lithium treatment. Brit. med. J.1968 III, 710–713.Google Scholar
  26. Sedvall, G., Jönsson, B., Petterson, U.: Evidence of an altered thyroid function in man during treatment with lithium carbonate. Acta psychiat. scand., suppl.207, 59–66 (1969).Google Scholar
  27. Shopsin, B., Blum, M., Gershon, S.: Lithium-induced thyroid disturbance: Case report and review. Comprehens. Psychiat.10, 215–223 (1969).Google Scholar
  28. Sielemann, W.: Einfluß psychotroper und sympathotroper Substanzen auf Schilddrüse, Sauerstoffverbrauch und Körpertemperatur von Ratten bei Kältebelastung. Diss., Med. Fak. Münster 1966.Google Scholar
  29. Smith, D. F., Balagura, S.: Antidotal thirst: A response to intoxication. Science167, 297–298 (1970).Google Scholar
  30. Stern, D. N., Fieve, R, R., Neff, N. H., Costa, E.: The effect of lithium chloride administration on brain and heart norepinephrine turnover rates. Psychopharmacologia (Berl.)14, 315–322 (1969).Google Scholar
  31. Strubelt, O.: Der Einfluß der Schilddrüsenfunktion auf die pharmakologischen Wirkungen von Propranolol, Adrenalin, Noradrenalin und Dinitrophenol. Arch. int. Pharmacodyn.176, 263–288 (1968).Google Scholar
  32. Trautner, E. M., Pennycuik, P. R., Morris, R. J. H., Gershon, S., Shankly, K. H.: The effects of prolonged sub-toxic lithium ingestion on pregnancy in rats. Aust. J. exp. Biol.36, 305–322 (1958).Google Scholar

Copyright information

© Springer-Verlag 1971

Authors and Affiliations

  • K. Opitz
    • 1
  • H. Chu
    • 1
  • H. Grüter
    • 1
  1. 1.Institut für Pharmakologie und Toxikologie und Institut für Medizinische Physik der Universität MünsterDeutschland

Personalised recommendations